Xarelto™ Lawsuit

Xarelto™ linked to increased risk of fatal bleeding events, stroke and death.

Xarelto™ is marketed by Bayer of Pennsylvania, and manufactured by Johnson and Johnson of New Jersey. Xarelto™ is prescribed to reduce the risk of clots and strokes in patients with atrial fibrillation. Xarelto™ is a blood thinner that inhibits thrombin, which is responsible for clotting. Bayer promotes Xarelto’s ease of use, lack of need for monitoring, and is more effective than Coumadin. The evidence contradicts each of these claims.

Additionally, unlike Coumadin, Xarelto™ remains without any antidote during a potentially fatal bleeding event, and the label fails to warn of this. Consequently, Xarelto™ is responsible for thousands of bleeding adverse events, many of which are fatal.

Call: 1-800-510-1325
FREE CONSULTATION
CONTACT US TODAY FOR A FREE LEGAL CONSULTATION WITH AN EXPERIENCED ATTORNEY.

Xarelto™ Side Effects

Since its approval for marketing in the U.S. by the FDA in 2011, Xarelto™ has been associated with thousands of adverse events, including:

Bleeding, often fatal

Stroke

Deep vein thrombosis

Pulmonary embolism

Thrombosis

Cerebrovascular accident

If you or a loved one suffered from one of these events while on Xarelto™, you may be entitled to compensation for your injuries and losses.
Call 1-800-510-1325
Xarelto™ (Rivaroxaban) Compared to Warfarin
The ROCKET AF Study results published in 2012 reported that GI bleeding events (upper GI, lower GI, and rectal bleeding) occurred more frequently in the 394 patients receiving Rivaroxaban than in the 290 receiving Warfarin. Major bleeding was more frequent with Rivaroxaban than with Warfarin (2.00% vs 1.24% per year).
About the Levensten Law Firm
The Levensten Law Firm, P.C. is nationally recognized for representing victims catastrophically injured by dangerous prescription drugs, including a blood thinner in the same class as Xarelto™. Our staff has the experience and knowledge to handle your claim from inception to resolution.